Posted by Michael Wonder on 12 Jan 2023
Eton Pharmaceuticals announces FDA acceptance of NDA response for dehydrated alcohol injection
11 January 2023 - Application assigned a PDUFA date of 27 June 2023.
Eton Pharmaceuticals today announced that the US FDA has accepted for review the Company’s new drug application response for dehydrated alcohol injection for the proposed indication of methanol poisoning.
